Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 14, 2018

DrugPatentWatch Database Preview

Heritage Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HERITAGE PHARMA, and what generic and branded alternatives to HERITAGE PHARMA drugs are available?

HERITAGE PHARMA has sixteen approved drugs.

Summary for Heritage Pharma

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	16
Patent Litigation for Heritage Pharma:	See patent lawsuits for Heritage Pharma

Drugs and US Patents for Heritage Pharma

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage Pharma	BUSPIRONE HYDROCHLORIDE	buspirone hydrochloride	TABLET;ORAL	204582-003	Sep 18, 2015	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Heritage Pharma	ACHROMYCIN V	tetracycline hydrochloride	CAPSULE;ORAL	050278-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Heritage Pharma	NIFEDIPINE	nifedipine	CAPSULE;ORAL	202644-002	Apr 25, 2013	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Heritage Pharma	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	TABLET;ORAL	204279-002	Aug 20, 2014	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Heritage Pharma	HYDROXYZINE PAMOATE	hydroxyzine pamoate	CAPSULE;ORAL	201507-001	Jun 3, 2013	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts

Cipla

Merck

Daiichi Sankyo

QuintilesIMS

Cantor Fitzgerald

Accenture

Deloitte

Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.